Powder: -20°C for 3 years | In solvent: -80°C for 1 year
MAO-B-IN-7 是有效的、具有血脑屏障渗透性的MAO-B 和AChE 抑制剂。MAO-B-IN-7抑制人 AChE、电鳗 AChE 和 MAO-B 的IC50分别为 41 nM、87 nM 和 0.3 μM。MAO-B-IN-7 可以有效缓解氧化应激和神经炎症损伤。
规格 | 价格/CNY | 货期 | 数量 | |
---|---|---|---|---|
25 mg | ¥ 10,600 | 10-14周 | ||
50 mg | ¥ 13,800 | 10-14周 | ||
100 mg | ¥ 17,500 | 10-14周 |
产品描述 | MAO-B-IN-7 is a potent and blood-brain barrier permeable MAO-B and AChE inhibitor. MAO-B-IN-7 exhibits IC50 s of 41 nM, 87 nM and 0.3 μM for human AChE, electric eel AChE and MAO-B, respectively. MAO-B-IN-7 effectively alleviates oxidative stress and neuroinflammatory damage. |
体外活性 | MAO-B-IN-7 (compound 7d) can effectively interact with Cu 2+ to form the corresponding complexes, and has good ability to inhibit ROS’s production induced by Cu 2+ [1]. MAO-B-IN-7 (10-100 μM; 24 hours) decreases the viability of PC-12 cells at 100 μM, but does not show obvious cytotoxicity at 10 and 25 μM [1]. MAO-B-IN-7 (4-25 μM; 24 hours) protects H 2 O 2 -induced PC-12 cells injury, and the cell viability are 80.2%, 71.1% and 56.3% at 25.0 μM, 10.0 μM and 4.0 μM, respectively. [1]. MAO-B-IN-7 (2.5 μM and 10 μM; 8 and 24 hours) inhibits ROS production induced by LPS in BV-2 cells in a dose-dependent manner; inhibits NO production with 30.4%, 43.5% and 58.9% at the concentrations of 0.5 μM, 2.5 μM and 10.0 μM, respectively; also inhibits TNF-α release with 32.7%, 47.8% and 63.2% at the concentrations of μM, 2.5 μM and 10.0 μM, respectively [1]. MAO-B-IN-7 exhibits the parallel artificial membrane permeation of 8.59 × 10 -6 in vitro blood-brain barrier permeation study [1]. Cell Cytotoxicity Assay Cell Line: PC-12 [1] Concentration: 10 μM, 25 μM, 100 μM Incubation Time: 24 hours Result: Decreased the viability of PC-12 cells at 100 μM. |
分子量 | 409.52 |
分子式 | C25H31NO4 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
对于不同动物的给药剂量换算,您也可以参考 更多...
请在以下方框中输入您的动物实验信息后点击计算,可以得到母液配置方法和体内配方的制备方法: 比如您的给药剂量是10 mg/kg,每只动物体重20 g,给药体积100 μL,一共给药动物10 只,您使用的配方为5% DMSO+30% PEG300+5% Tween 80+60% ddH2O。那么您的工作液浓度为2 mg/mL。
母液配置方法:2 mg 药物溶于 50 μL DMSO (母液浓度为 40 mg/mL), 如您需要配置的浓度超过该产品的溶解度,请先与我们联系。
体内配方的制备方法:取 50 μL DMSO 主液,加入 300 μL PEG300, 混匀澄清,再加 50 μL Tween 80,混匀澄清,再加 600 μL ddH2O, 混匀澄清。
您可能有的问题的答案可以在抑制剂处理说明中找到,包括如何准备库存溶液,如何存储产品,以及基于细胞的分析和动物实验需要特别注意的问题。
MAO-B-IN-7 Inhibitor inhibitor inhibit